204 related articles for article (PubMed ID: 35001204)
41. The Role of the Human Visual Cortex in Assessment of the Long-Term Durability of Retinal Gene Therapy in Follow-on RPE65 Clinical Trial Patients.
Ashtari M; Nikonova ES; Marshall KA; Young GJ; Aravand P; Pan W; Ying GS; Willett AE; Mahmoudian M; Maguire AM; Bennett J
Ophthalmology; 2017 Jun; 124(6):873-883. PubMed ID: 28237426
[TBL] [Abstract][Full Text] [Related]
42. Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic
Kiraly P; Cottriall CL; Taylor LJ; Jolly JK; Cehajic-Kapetanovic J; Yusuf IH; Martinez-Fernandez de la Camara C; Shanks M; Downes SM; MacLaren RE; Fischer MD
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892166
[TBL] [Abstract][Full Text] [Related]
43. Full-field Scotopic Threshold Improvement after Voretigene Neparvovec-rzyl Treatment Correlates with Chorioretinal Atrophy.
Stingl K; Stingl K; Schwartz H; Reid MW; Kempf M; Dimopoulos S; Kortuem F; Borchert MS; Lee TC; Nagiel A
Ophthalmology; 2023 Jul; 130(7):764-770. PubMed ID: 36822437
[TBL] [Abstract][Full Text] [Related]
44. Long-term effect of gene therapy on Leber's congenital amaurosis.
Bainbridge JW; Mehat MS; Sundaram V; Robbie SJ; Barker SE; Ripamonti C; Georgiadis A; Mowat FM; Beattie SG; Gardner PJ; Feathers KL; Luong VA; Yzer S; Balaggan K; Viswanathan A; de Ravel TJ; Casteels I; Holder GE; Tyler N; Fitzke FW; Weleber RG; Nardini M; Moore AT; Thompson DA; Petersen-Jones SM; Michaelides M; van den Born LI; Stockman A; Smith AJ; Rubin G; Ali RR
N Engl J Med; 2015 May; 372(20):1887-97. PubMed ID: 25938638
[TBL] [Abstract][Full Text] [Related]
45. The phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis.
Weleber RG; Michaelides M; Trzupek KM; Stover NB; Stone EM
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):292-302. PubMed ID: 20811047
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
Li S; Samardzija M; Yang Z; Grimm C; Jin M
J Neurosci; 2016 May; 36(21):5808-19. PubMed ID: 27225770
[TBL] [Abstract][Full Text] [Related]
47. Spatial and temporal resolution of the photoreceptors rescue dynamics after treatment with voretigene neparvovec.
Stingl K; Kempf M; Bartz-Schmidt KU; Dimopoulos S; Reichel F; Jung R; Kelbsch C; Kohl S; Kortüm FC; Nasser F; Peters T; Wilhelm B; Wissinger B; Wozar F; Zrenner E; Fischer MD; Stingl K
Br J Ophthalmol; 2022 Jun; 106(6):831-838. PubMed ID: 33472769
[TBL] [Abstract][Full Text] [Related]
48. Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis.
Lidder AK; Choi S; Modi YS; Brodie SE; Davis JL; Gregori NZ; Lam BL
Am J Ophthalmol Case Rep; 2023 Dec; 32():101879. PubMed ID: 37521805
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Ocular Gene Therapy in an Italian Patient Affected by Congenital Leber Amaurosis Type 2 Treated in Both Eyes.
Testa F; Maguire AM; Rossi S; Marshall K; Auricchio A; Melillo P; Bennett J; Simonelli F
Adv Exp Med Biol; 2016; 854():533-9. PubMed ID: 26427456
[TBL] [Abstract][Full Text] [Related]
50. A novel mutation in the RPE65 gene causing Leber congenital amaurosis and its transcriptional expression in vitro.
Mo G; Ding Q; Chen Z; Li Y; Yan M; Bu L; Song Y; Yin G
PLoS One; 2014; 9(11):e112400. PubMed ID: 25383945
[TBL] [Abstract][Full Text] [Related]
51. [Gene therapy for vision restoration in patients with Leber congenital amaurosis (LCA) due to RPE65 gene mutations: beginning the phase IV trial].
Chacón-Camacho ÓF; Zenteno JC
Gac Med Mex; 2017; 153(2):276-278. PubMed ID: 28474714
[TBL] [Abstract][Full Text] [Related]
52. Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations.
Jacobson SG; Aleman TS; Cideciyan AV; Roman AJ; Sumaroka A; Windsor EA; Schwartz SB; Heon E; Stone EM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2368-75. PubMed ID: 19117922
[TBL] [Abstract][Full Text] [Related]
53. Treatment Potential for LCA5-Associated Leber Congenital Amaurosis.
Uyhazi KE; Aravand P; Bell BA; Wei Z; Leo L; Serrano LW; Pearson DJ; Shpylchak I; Pham J; Vasireddy V; Bennett J; Aleman TS
Invest Ophthalmol Vis Sci; 2020 May; 61(5):30. PubMed ID: 32428231
[TBL] [Abstract][Full Text] [Related]
54. Voretigene Neparvovec for the Treatment of RPE65-associated Retinal Dystrophy: Consensus and Recommendations from the Korea RPE65-IRD Consensus Paper Committee.
Han J; Joo K; Kim US; Woo SJ; Lee EK; Lee JY; Park TK; Kim SJ; Byeon SH
Korean J Ophthalmol; 2023 Apr; 37(2):166-186. PubMed ID: 36950921
[TBL] [Abstract][Full Text] [Related]
55. Retinal gene therapy in RPE-65 gene mediated inherited retinal dystrophy.
Jalil A; Ivanova T; Moussa G; Parry NRA; Black GCM
Eye (Lond); 2023 Jun; 37(9):1874-1877. PubMed ID: 36163489
[TBL] [Abstract][Full Text] [Related]
56. Voretigene Neparvovec Gene Therapy in Clinical Practice: Treatment of the First Two Italian Pediatric Patients.
Testa F; Melillo P; Della Corte M; Di Iorio V; Brunetti-Pierri R; Citro A; Ferrara M; Karali M; Annibale R; Banfi S; Rossi S; Simonelli F
Transl Vis Sci Technol; 2021 Aug; 10(10):11. PubMed ID: 34554209
[TBL] [Abstract][Full Text] [Related]
57. Gene therapy for Leber congenital amaurosis: advances and future directions.
Hufnagel RB; Ahmed ZM; Corrêa ZM; Sisk RA
Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1117-28. PubMed ID: 22644094
[TBL] [Abstract][Full Text] [Related]
58. Voretigene Neparvovec in Retinal Diseases: A Review of the Current Clinical Evidence.
Gao J; Hussain RM; Weng CY
Clin Ophthalmol; 2020; 14():3855-3869. PubMed ID: 33223822
[TBL] [Abstract][Full Text] [Related]
59. Defining Outcomes for Clinical Trials of Leber Congenital Amaurosis Caused by GUCY2D Mutations.
Jacobson SG; Cideciyan AV; Sumaroka A; Roman AJ; Charng J; Lu M; Choudhury S; Schwartz SB; Heon E; Fishman GA; Boye SE
Am J Ophthalmol; 2017 May; 177():44-57. PubMed ID: 28212877
[TBL] [Abstract][Full Text] [Related]
60. Cone-rod dystrophy caused by a novel homozygous RPE65 mutation in Leber congenital amaurosis.
Jakobsson C; Othman IS; Munier FL; Schorderet DF; Abouzeid H
Klin Monbl Augenheilkd; 2014 Apr; 231(4):405-10. PubMed ID: 24771178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
